Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ATRX loss promotes immunosuppressive mechanisms in IDH1 mutant glioma
Chengchen Hu, Kimberly Wang, Ceylan Damon, et al.
Neuro-Oncology (2021) Vol. 24, Iss. 6, pp. 888-900
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Hepatocyte HSPA12A inhibits macrophage chemotaxis and activation to attenuate liver ischemia/reperfusion injury via suppressing glycolysis-mediated HMGB1 lactylation and secretion of hepatocytes
Shuya Du, Xiaojin Zhang, Yunxiao Jia, et al.
Theranostics (2023) Vol. 13, Iss. 11, pp. 3856-3871
Open Access | Times Cited: 55
Dysfunctional dendritic cells limit antigen-specific T cell response in glioma
Mirco Friedrich, Markus Hahn, Julius Michel, et al.
Neuro-Oncology (2022) Vol. 25, Iss. 2, pp. 263-276
Open Access | Times Cited: 57
Impact of epigenetic reprogramming on antitumor immune responses in glioma
Brandon L. McClellan, Santiago Haase, Felipe J. Núñez, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 2
Open Access | Times Cited: 39
The Chromatin Remodeler ATRX: Role and Mechanism in Biology and Cancer
Ying Pang, Xu Chen, Tongjie Ji, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2228-2228
Open Access | Times Cited: 23
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas
Seethalakshmi Hariharan, Benjamin T. Whitfield, Christopher J. Pirozzi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
BRD4: New hope in the battle against glioblastoma
Weichen Duan, Miao Yu, Jiajia Chen
Pharmacological Research (2023) Vol. 191, pp. 106767-106767
Open Access | Times Cited: 18
Deciphering Glioblastoma: Fundamental and Novel Insights into the Biology and Therapeutic Strategies of Gliomas
Răzvan Onciul, Felix-Mircea Brehar, Corneliu Toader, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 3, pp. 2402-2443
Open Access | Times Cited: 8
Epigenetic regulation of tumor-immune symbiosis in glioma
Yang Liu, Heba Ali, Fatima Khan, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 5, pp. 429-442
Open Access | Times Cited: 6
Exploring glioblastoma stem cell heterogeneity: Immune microenvironment modulation and therapeutic opportunities
Amanda Johnson, John Laterra, Hernando López-Bertoni
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 21
Deep visual proteomics reveals DNA replication stress as a hallmark of signet ring cell carcinoma
Sonja Kabatnik, Xiang Zheng, George D. Pappas, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Unravelling the modified T cell receptor through Gen-Next CAR T cell therapy in Glioblastoma: Current status and future challenges
Bhavya Bhutani, Vinay Sharma, Nirmal Kumar Ganguly, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 117987-117987
Closed Access
M2型巨噬细胞在胶质母细胞瘤中代谢机制和临床管理
马晨诚, 束汉生, 朱叶山, et al.
(2025) Vol. 1, Iss. 1, pp. 28-39
Closed Access
From pathology to therapy: A comprehensive review of ATRX mutation related molecular functions and disorders
Fan Xu, Daohan Yu, Jiazheng Guo, et al.
Mutation Research/Reviews in Mutation Research (2025) Vol. 795, pp. 108537-108537
Closed Access
Integrating Multiplex Immunohistochemistry and Machine Learning for Glioma Subtyping and Prognosis Prediction
Houshi Xu, Zhen Fan, Shan Jiang, et al.
MedComm (2025) Vol. 6, Iss. 5
Open Access
IDH Mutations in Chondrosarcoma: Case Closed or Not?
Sanne Venneker, Judith V.M.G. Bovée
Cancers (2023) Vol. 15, Iss. 14, pp. 3603-3603
Open Access | Times Cited: 9
Notopterol improves cognitive dysfunction and depression-like behavior via inhibiting STAT3/NF-ĸB pathway mediated inflammation in glioma-bearing mice
Zheng‐Jun Zhou, You Zhou, Zhengxuan Huang, et al.
International Immunopharmacology (2023) Vol. 118, pp. 110041-110041
Open Access | Times Cited: 7
Insight into the Progress in CAR-T Cell Therapy and Combination with Other Therapies for Glioblastoma
Tingyu Liang, Yixuan Song, Lingui Gu, et al.
International Journal of General Medicine (2023) Vol. Volume 16, pp. 4121-4141
Open Access | Times Cited: 7
DNA Damage Response Evaluation Provides Novel Insights for Personalized Immunotherapy in Glioma
Mu Chen, Bingsong Huang, Lei Zhu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Characterization of Different Subtypes of Immune Cell Infiltration in Glioblastoma to Aid Immunotherapy
Peng Feng, Zhenqing Li, Yuchen Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Knockdown of ATRX enhances radiosensitivity in glioblastoma
Yue Zhao, Yifei Chen, Ruo-Yu Liu, et al.
Chinese Neurosurgical Journal (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Distinct gene mutation profiles among multiple and single primary lung adenocarcinoma
Yadong Wang, Guanghui Wang, Haotian Zheng, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
Pooled genetic screens to identify vulnerabilities in TERT-promoter-mutant glioblastoma
Kevin J. Tu, Connor E. Stewart, Peter G. Hendrickson, et al.
Oncogene (2023) Vol. 42, Iss. 44, pp. 3274-3286
Open Access | Times Cited: 4
Oncometabolite 2-hydroxyglutarate suppresses basal protein levels of DNA polymerase beta that enhances alkylating agent and PARG inhibition induced cytotoxicity
Kate M. Saville, Rasha Q. Al‐Rahahleh, Aisha H. Siddiqui, et al.
DNA repair (2024) Vol. 140, pp. 103700-103700
Open Access | Times Cited: 1
Metastatic perirectal PEComa treated by checkpoint inhibitor immunotherapy and multimodal treatment: case report and review of the literature
Maxime Rémond, Atanas Pachev, Maxime Battistella, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 1
Mutant ATRX: pathogenesis of ATRX syndrome and cancer
Kejia Yuan, Yan Tang, Zexian Ding, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top